392 related articles for article (PubMed ID: 32684234)
1. Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An
Xu YH; Yang J; Meng J; Wang H
Chin Med Sci J; 2020 Jun; 35(2):142-150. PubMed ID: 32684234
[TBL] [Abstract][Full Text] [Related]
2. RGD-functionalized ultrasmall iron oxide nanoparticles for targeted T₁-weighted MR imaging of gliomas.
Luo Y; Yang J; Yan Y; Li J; Shen M; Zhang G; Mignani S; Shi X
Nanoscale; 2015 Sep; 7(34):14538-46. PubMed ID: 26260703
[TBL] [Abstract][Full Text] [Related]
3. Conjugation of iron oxide nanoparticles with RGD-modified dendrimers for targeted tumor MR imaging.
Yang J; Luo Y; Xu Y; Li J; Zhang Z; Wang H; Shen M; Shi X; Zhang G
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5420-8. PubMed ID: 25695661
[TBL] [Abstract][Full Text] [Related]
4. Facile synthesis of RGD peptide-modified iron oxide nanoparticles with ultrahigh relaxivity for targeted MR imaging of tumors.
Hu Y; Li J; Yang J; Wei P; Luo Y; Ding L; Sun W; Zhang G; Shi X; Shen M
Biomater Sci; 2015 May; 3(5):721-32. PubMed ID: 26222591
[TBL] [Abstract][Full Text] [Related]
5. Active-target T1-weighted MR Imaging of Tiny Hepatic Tumor via RGD Modified Ultra-small Fe3O4 Nanoprobes.
Jia Z; Song L; Zang F; Song J; Zhang W; Yan C; Xie J; Ma Z; Ma M; Teng G; Gu N; Zhang Y
Theranostics; 2016; 6(11):1780-91. PubMed ID: 27570550
[TBL] [Abstract][Full Text] [Related]
6. Redox-Sensitive Clustered Ultrasmall Iron Oxide Nanoparticles for Switchable T
Ma D; Shi M; Li X; Zhang J; Fan Y; Sun K; Jiang T; Peng C; Shi X
Bioconjug Chem; 2020 Feb; 31(2):352-359. PubMed ID: 31693856
[TBL] [Abstract][Full Text] [Related]
7. Novel MR imaging nanoprobe for hepatocellular carcinoma detection based on manganese-zinc ferrite nanoparticles: in vitro and in vivo assessments.
Sobhani T; Shahbazi-Gahrouei D; Zahraei M; Hejazi SH; Dousti F; Rostami M
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4939-4957. PubMed ID: 36309602
[TBL] [Abstract][Full Text] [Related]
8. Facile Synthesis of Folic Acid-Modified Iron Oxide Nanoparticles for Targeted MR Imaging in Pulmonary Tumor Xenografts.
Zhang Z; Hu Y; Yang J; Xu Y; Zhang C; Wang Z; Shi X; Zhang G
Mol Imaging Biol; 2016 Aug; 18(4):569-78. PubMed ID: 26620721
[TBL] [Abstract][Full Text] [Related]
9. Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging.
Li J; Zheng L; Cai H; Sun W; Shen M; Zhang G; Shi X
Biomaterials; 2013 Nov; 34(33):8382-92. PubMed ID: 23932250
[TBL] [Abstract][Full Text] [Related]
10. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.
Li X; Xia S; Zhou W; Ji R; Zhan W
Int J Nanomedicine; 2019; 14():2397-2413. PubMed ID: 31040664
[TBL] [Abstract][Full Text] [Related]
11. Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T
Gao L; Yu J; Liu Y; Zhou J; Sun L; Wang J; Zhu J; Peng H; Lu W; Yu L; Yan Z; Wang Y
Theranostics; 2018; 8(1):92-108. PubMed ID: 29290795
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging.
Li J; He Y; Sun W; Luo Y; Cai H; Pan Y; Shen M; Xia J; Shi X
Biomaterials; 2014 Apr; 35(11):3666-77. PubMed ID: 24462358
[TBL] [Abstract][Full Text] [Related]
13. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
14. Lipid-coated iron oxide nanoparticles for dual-modal imaging of hepatocellular carcinoma.
Liang J; Zhang X; Miao Y; Li J; Gan Y
Int J Nanomedicine; 2017; 12():2033-2044. PubMed ID: 28352173
[TBL] [Abstract][Full Text] [Related]
15. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
16. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and application of strawberry-like Fe3O4-Au nanoparticles as CT-MR dual-modality contrast agents in accurate detection of the progressive liver disease.
Zhao HY; Liu S; He J; Pan CC; Li H; Zhou ZY; Ding Y; Huo D; Hu Y
Biomaterials; 2015 May; 51():194-207. PubMed ID: 25771010
[TBL] [Abstract][Full Text] [Related]
18. Dual-targeting and excretable ultrasmall SPIONs for T
Du C; Liu X; Hu H; Li H; Yu L; Geng D; Chen Y; Zhang J
J Mater Chem B; 2020 Mar; 8(11):2296-2306. PubMed ID: 32100784
[TBL] [Abstract][Full Text] [Related]
19. Folic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancer.
Zhang H; Li J; Hu Y; Shen M; Shi X; Zhang G
J Ovarian Res; 2016 Mar; 9():19. PubMed ID: 27025582
[TBL] [Abstract][Full Text] [Related]
20. LAPONITE®-stabilized iron oxide nanoparticles for in vivo MR imaging of tumors.
Ding L; Hu Y; Luo Y; Zhu J; Wu Y; Yu Z; Cao X; Peng C; Shi X; Guo R
Biomater Sci; 2016 Mar; 4(3):474-82. PubMed ID: 26730414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
